Eli Lilly launches late-stage antibody treatment trial to be tested in US nursing homes
By SONY SALZMAN, ABC News(NEW YORK) -- In many ways, America's nursing homes have become the front lines of the coronavirus pandemic, as the facilities are linked to about 40% of COVID-19 deaths.Now, the pharmaceutical firm Eli Lilly... Read More.
